Michael Silk is a biotechnology and pharmaceutical executive with 18 years of experience in marketing and commercial development, specializing in oncology among other disease states. Michael has held significant leadership roles, most recently as Vice President of Commercial Oncology at AbbVie since 2024 and previously as Vice President and US Franchise Head for Hematologic Oncology at Sanofi from 2021 to 2024. Michael has successfully led marketing initiatives, product launches, and strategic planning across various organizations, including Takeda Oncology and EMD Serono. Michael holds an MBA in Marketing from The Wharton School at the University of Pennsylvania and a BS in Commerce/Economics from the University of Virginia.
This person is not in any teams
This person is not in any offices